Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

RCE-ESMO-ESO Training Course for Rare Cancer Patient Advocates 2021 Online Training

Start date
14 Jan 2021
End date
21 Jan 2021


RCE-ESMO-ESO rare cancer patient advocates training course 2021 virtually took place over multiple days, from 14 January to 21 January. Throughout several sessions the participants were informed about the latest update on Rare Cancers on the EU Agenda and the attendees had the opportunity to participate to the Patient Cafés focused on COVID-19 and rare cancers, patient involvement in clinical trials, patient involvement in clinical registries, and patient involvement in tumor banks.  .

Please find here the agenda of the RCE-ESMO-ESO rare cancer patient advocates training course 2021

Session 1: Rare Cancers on the EU Agenda

Session 2: COVID-19 and cancer: lessons learned, pathway for the future

Session 3: Patient involvement in clinical research was composed of three different sub-sessions of one hour each.  

Patient involvement in clinical trials
Patient involvement in clinical registries
Patient involvement in tumour banks

Like in the previous editions the Rare Cancer Patient Advocates Training Course 2021 was organised in synergy with the 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers.

For any clarification requests please contact the RCE Secretariat:  rarecancerseurope@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.